Navigator Global Investments Ltd
Navigator Global Investments Limited is an Australia-based diversified alternative asset management company.
The business
Navigator Global Investments Limited is an Australia-based diversified alternative asset management company. The Company is engaged in investing in a range of diversified alternative asset management companies, through partnering with management teams who operate institutional businesses globally. The Company operates through two segments: Lighthouse Group and NGI Strategic. Lighthouse Group operates as a global absolute return funds manager for investment vehicles. The NGI Strategic segment holds several strategic investments on a minority basis, including the NGI Strategic Portfolio, Marble Capital, Invictus Capital Partners and 1315 Capital investments. Marble Capital is a fully discretionary fund manager providing capital solutions throughout all parts of the capital stack for multifamily developers and operators. Lighthouse Investment Partners, LLC is a subsidiary of the Company which is a globally diversified alternative asset management firm.
Small Caps Research
No research on Navigator Global Investments Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise NGI based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Navigator Global to Cash-In Invictus Capital Partners Investment after Acquisition by US Asset Firm
Navigator Global to cash in Invictus stake as NYLIM takes 60%: upfront US$43m, potential US$32m earn-out, with 2031 exit for remaining interests.
Navigator Global Investments acquires 23.5% stake in US private equity firm 1315 Capital
Alternative asset management company Navigator Global Investments (ASX: NGI) will pay approximately $111.4 million (US$70.5m) to acquire a 23.5% strategic equity stake in US healthcare private equity firm 1315 Capital and its affiliates. 1315 Capital has more than US$1 billion in managed assets, providing growth equity and buyout capital for commercial-stage pharmaceutical outsourcing, health and […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.